| P50 | author | Emma J. Kidd | Q42967000 |
| P2093 | author name string | B A J Evans | |
| | S M Alqallaf | |
| P2860 | cites work | Evidence for functional P2X4/P2X7 heteromeric receptors | Q24292728 |
| | Proteomic and functional evidence for a P2X7 receptor signalling complex | Q24535912 |
| | The P2X7 receptor is a candidate product of murine and human lupus susceptibility loci: a hypothesis and comparison of murine allelic products | Q24816641 |
| | Expression of a P2X7 receptor by a subpopulation of human osteoblasts | Q28187667 |
| | Blockade of the pore-forming P2X7 receptor inhibits formation of multinucleated human osteoclasts in vitro | Q28188795 |
| | International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits | Q28199881 |
| | Molecular physiology of P2X receptors | Q28203477 |
| | A loss-of-function polymorphic mutation in the cytolytic P2X7 receptor gene and chronic lymphocytic leukaemia: a molecular study | Q28214084 |
| | Neuronal P2X7 receptors are targeted to presynaptic terminals in the central and peripheral nervous systems | Q28215870 |
| | Extracellular adenosine 5'-triphosphate induces a loss of CD23 from human dendritic cells via activation of P2X7 receptors | Q28216255 |
| | Pharmacology of P2X channels | Q28237411 |
| | Tissue distribution of the P2X7 receptor | Q28254153 |
| | Effects of antagonists at the human recombinant P2X7 receptor | Q28368511 |
| | The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7) | Q28568856 |
| | Altered cytokine production in mice lacking P2X(7) receptors | Q28586061 |
| | Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response | Q28589548 |
| | Secretion of intracellular IL-1 receptor antagonist (type 1) is dependent on P2X7 receptor activation | Q28591668 |
| | Deletion of the P2X7 nucleotide receptor reveals its regulatory roles in bone formation and resorption | Q28594371 |
| | Nucleotide receptors: an emerging family of regulatory molecules in blood cells | Q28678595 |
| | Expression of P2 receptors in human B cells and Epstein-Barr virus-transformed lymphoblastoid cell lines. | Q33257485 |
| | Cytolytic P2X purinoceptors. | Q33592245 |
| | Molecular and functional characterization of human P2X(2) receptors. | Q33881010 |
| | Molecular physiology of P2X receptors and ATP signalling at synapses | Q34188163 |
| | A C-terminal lysine that controls human P2X4 receptor desensitization | Q34501713 |
| | Regulation of bone resorption and formation by purines and pyrimidines | Q35161577 |
| | An antibody to the beta-secretase cleavage site on amyloid-beta-protein precursor inhibits amyloid-beta production. | Q35822309 |
| | Molecular properties of ATP-gated P2X receptor ion channels | Q35960338 |
| | A historical review of cellular calcium handling, with emphasis on mitochondria. | Q36088211 |
| | Spontaneous cell fusion in macrophage cultures expressing high levels of the P2Z/P2X7 receptor | Q36276387 |
| | Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin | Q36376502 |
| | P2X7 receptors in the nervous system | Q36476984 |
| | Epidermal growth factor facilitates epinephrine inhibition of P2X7-receptor-mediated pore formation and apoptosis: a novel signaling network | Q36692768 |
| | Characterization of ionotrophic purinergic receptors in hepatocytes | Q40047618 |
| | Establishment of an assay for P2X7 receptor-mediated cell death. | Q40211724 |
| | Human melanomas express functional P2 X(7) receptors. | Q40403150 |
| | P2X and P2Y purinergic receptors on human intestinal epithelial carcinoma cells: effects of extracellular nucleotides on apoptosis and cell proliferation. | Q40468184 |
| | Expression of P2X7 in human hematopoietic cell lines and leukemia patients. | Q40505934 |
| | Are second messengers crucial for opening the pore associated with P2X7 receptor? | Q40506943 |
| | P2X7 receptor-mediated apoptosis of human cervical epithelial cells | Q40532869 |
| | Antagonist effects on human P2X(7) receptor-mediated cellular accumulation of YO-PRO-1. | Q40878368 |
| | Apparent species differences in the kinetic properties of P2X(7) receptors | Q40883984 |
| | Pore dilation of neuronal P2X receptor channels | Q40960421 |
| | Ionic effects on human recombinant P2X7 receptor function | Q40970589 |
| | Properties of the pore-forming P2X7 purinoceptor in mouse NTW8 microglial cells | Q41097625 |
| | Nucleotide receptors | Q41541504 |
| | Basolateral P2X4-like receptors regulate the extracellular ATP-stimulated epithelial Na+ channel activity in renal epithelia. | Q42170437 |
| | Guide to Receptors and Channels (GRAC), 3rd edition | Q43088119 |
| | Brilliant blue G selectively blocks ATP-gated rat P2X(7) receptors. | Q43504221 |
| | Activity-dependent development of P2X7 current and Ca2+ entry in rabbit osteoclasts | Q43701646 |
| | P2X7 subunit-like immunoreactivity in the nucleus of visceral smooth muscle cells of the guinea pig. | Q44523662 |
| | Antiapoptotic effects of estrogen in normal and cancer human cervical epithelial cells | Q45023517 |
| | Large pore formation uniquely associated with P2X7 purinergic receptor channels. Focus on "Are second messengers crucial for opening the pore associated with P2X7 receptor?". | Q45219043 |
| | Extracellular ATP induces cytokine expression and apoptosis through P2X7 receptor in murine mast cells | Q46391153 |
| | Expanding the range of free calcium regulation in biological solutions | Q46804677 |
| | Isoquinolines as antagonists of the P2X7 nucleotide receptor: high selectivity for the human versus rat receptor homologues | Q47866845 |
| | Ivermectin potentiates ATP-induced ion currents in cortical neurones: evidence for functional expression of P2X4 receptors? | Q48137289 |
| | Pharmacological characterization of recombinant human and rat P2X receptor subtypes | Q48911279 |
| | ATP activates DNA synthesis by acting on P2X receptors in human osteoblast-like MG-63 cells. | Q50510498 |
| | ATP4- permeabilizes the plasma membrane of mouse macrophages to fluorescent dyes. | Q50902451 |
| | Radioligand binding and functional responses of ligands for human recombinant adenosine A(3) receptors. | Q51809194 |
| | Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemia | Q57350629 |
| | Intercellular Calcium Signaling Occurs between Human Osteoblasts and Osteoclasts and Requires Activation of Osteoclast P2X7 Receptors | Q63729226 |
| | P2Z adenosine triphosphate receptor activity in cultured human monocyte-derived macrophages | Q72698991 |
| | Expression of P2 receptors in bone and cultured bone cells | Q73082209 |
| | Non-genomic inhibition of human P2X7 purinoceptor by 17beta-oestradiol | Q74367721 |
| | P2Z/P2X7 receptor-dependent apoptosis of dendritic cells | Q77755507 |
| | Differential expression patterns of mRNAs for P2X receptor subunits in neurochemically characterized dorsal root ganglion neurons in the rat | Q81129392 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacology | Q128406 |
| | osteoblast | Q917177 |
| P304 | page(s) | 1124-1135 | |
| P577 | publication date | 2009-02-18 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Atypical P2X receptor pharmacology in two human osteoblast-like cell lines | |
| P478 | volume | 156 | |